KBC Group NV cut its holdings in Envision Healthcare Co. (NYSE:EVHC) by 39.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,758 shares of the company’s stock after selling 10,827 shares during the period. KBC Group NV’s holdings in Envision Healthcare were worth $579,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of EVHC. CIBC World Markets Inc. bought a new stake in Envision Healthcare in the fourth quarter worth $208,000. Palisade Capital Management LLC NJ bought a new stake in Envision Healthcare in the third quarter worth $229,000. CENTRAL TRUST Co boosted its holdings in Envision Healthcare by 79.7% in the fourth quarter. CENTRAL TRUST Co now owns 6,626 shares of the company’s stock worth $229,000 after purchasing an additional 2,939 shares in the last quarter. Alps Advisors Inc. bought a new stake in Envision Healthcare in the fourth quarter worth $235,000. Finally, M&T Bank Corp boosted its holdings in Envision Healthcare by 33.6% in the fourth quarter. M&T Bank Corp now owns 6,818 shares of the company’s stock worth $235,000 after purchasing an additional 1,716 shares in the last quarter.
Shares of Envision Healthcare Co. (NYSE EVHC) opened at $36.74 on Wednesday. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. Envision Healthcare Co. has a one year low of $23.77 and a one year high of $72.50. The firm has a market cap of $4,433.01, a PE ratio of -7.35, a P/E/G ratio of 0.95 and a beta of 0.58.
EVHC has been the subject of a number of recent analyst reports. Robert W. Baird set a $45.00 price target on shares of Envision Healthcare and gave the company a “buy” rating in a report on Monday. Cantor Fitzgerald restated a “hold” rating and set a $37.00 price target on shares of Envision Healthcare in a report on Wednesday, February 21st. KeyCorp decreased their price target on shares of Envision Healthcare from $67.00 to $37.00 and set an “overweight” rating for the company in a report on Thursday, November 2nd. Mizuho set a $57.00 price target on shares of Envision Healthcare and gave the company a “hold” rating in a report on Tuesday, October 31st. Finally, Stephens restated a “hold” rating and set a $34.00 price target on shares of Envision Healthcare in a report on Wednesday, January 10th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and nine have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $42.50.
ILLEGAL ACTIVITY NOTICE: “KBC Group NV Sells 10,827 Shares of Envision Healthcare Co. (EVHC)” was first published by Ticker Report and is owned by of Ticker Report. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and international trademark & copyright laws. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3227584/kbc-group-nv-sells-10827-shares-of-envision-healthcare-co-evhc.html.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Co. (NYSE:EVHC).
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.